COVID-19 Pandemic and Surgical Oncology: Preserving the Academic Mission

[1]  K. Hunt,et al.  COVID-19 Guideline Modifications as CMS Announces “Opening Up America Again”: Comments from the Society of Surgical Oncology , 2020, Annals of Surgical Oncology.

[2]  Wei Xu,et al.  Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  D. Haidopoulos,et al.  The impact of waiting intervals on survival outcomes of patients with endometrial cancer: A systematic review of the literature. , 2020, European journal of obstetrics, gynecology, and reproductive biology.

[4]  Mark Payne,et al.  Health and Human Services , 2020, Congress and the Nation 2013-2016, Volume XIV: Politics and Policy in the 113th and 114th Congresses.

[5]  T. J. Moore,et al.  Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015-2016 , 2018, JAMA internal medicine.

[6]  R. Noone.  The American Board of Medical Specialties. , 2013, Plastic and reconstructive surgery.

[7]  B. Friedman,et al.  Microsimulation of financial impact of demand surge on hospitals: the H1N1 influenza pandemic of fall 2009. , 2013, Health services research.

[8]  Accreditation Council for Graduate Medical Education Mourns Marvin R. Dunn, Director of Residency Review Committee Activities , 2003, Journal of Investigative Medicine.